Physician profile
Arash Amadi
NPI 1225112063
$6,694.31
in general payments reported to CMS, 2019-2025
14 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $158 · 2021: $330 · 2022: $587 · 2023: $1,707 · 2024: $1,909 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,332 · Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,331.65 |
| Food and Beverage | $847.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,476.48 | 2023-2025 | Botox |
| Allergan, INC. | $1,155.16 | 2019-2023 | |
| Horizon Therapeutics Plc | $237.61 | 2019-2020 | |
| Galderma Laboratories, L.P. | $205.02 | 2019-2024 | |
| Amgen INC. | $135.58 | 2024 | Tepezza |
| Stryker Corporation | $132.84 | 2019 | |
| Kls-Martin L.P. | $116.00 | 2025 | |
| Revance Therapeutics, INC. | $82.43 | 2025 | Daxxify |
| Axogen | $53.43 | 2021-2022 | |
| Motiva USA, LLC | $26.51 | 2025 | |
| Mentor Worldwide LLC | $22.04 | 2025 | Mentor Siltex Round Spectrum |
| Baxter Healthcare | $21.21 | 2025 | Tisseel |
| Cook Medical LLC | $15.06 | 2023 | Zilver Ptx |
| Merz North America, INC. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Amadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.